GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today shared the results of a study ...
BEVERLY, Mass.-- (BUSINESS WIRE)--February 24, 2026-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results ...
Inogen devices are known for their superior patient compliance, monitoring and diagnostic capabilities and we know that continued investment in our platforms to improve their ease of use and cost ...
“2024 was a very successful year for Inogen (INGN). We drove a return to revenue growth, improved profitability and disciplined cost management. Achievements in the quarter included the launch of Rove ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction ...
An update from Inogen ( (INGN)) is now available. Inogen reported its fourth-quarter and full-year 2025 results on February 24, 2026, showing 2025 revenue up 3.9% to $348.7 million, driven by strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results